Pharma Journalist 8801 posts 0 comments

Advaxis, Inc. and Personalis Inc. announced a collaboration to leverage Personalis’ ImmunoID NeXT Platform in Advaxis’ ongoing Phase 1/2 ADXS-503 (HOT Lung) program evaluating ADXS-503…
Read More...

Ligand Pharmaceuticals Incorporated announces the signing of an agreement whereby Ligand will acquire the core assets of Icagen, Inc.’s North Carolina operations, including partnered…
Read More...

LakePharma, Inc. and NJ Biopharmaceuticals LLC  announce the formation of a strategic alliance to offer streamlined antibody-drug conjugate (ADC) development solutions for the…
Read More...

ReForm Biologics LLC, a pharmaceutical technology company developing innovative platforms to improve biologic formulations and MilliporeSigma announced a global license agreement and…
Read More...

Catalent, Inc. announced that it had completed its acquisition of MaSTherCell Global Inc., positioning Catalent as a premier technology, development and manufacturing partner for…
Read More...

Biohaven Pharmaceutical Holding Company Ltd. reported negative topline results from its Phase 3 clinical trial evaluating troriluzole compared to placebo for the treatment of patients…
Read More...

Eli Lilly and Company announced that the analysis performed by Washington University School of Medicine in the Dominantly Inherited Alzheimer Network Trials Unit (DIAN-TU) Study showed…
Read More...

Kite, a Gilead Company announced that the U.S. Food and Drug Administration (FDA) has accepted the Biologics License Application (BLA) and granted Priority Review designation for…
Read More...

SMi Reports: The AI in Drug Discovery conference will feature a panel discussion with panellists from Novartis, OMass Therapeutics, Domaineux and AstraZeneca. SMi Group’s inaugural AI…
Read More...

With just three weeks until the RAS- Targeted Drug Discovery Summit Europe, don’t miss this unique opportunity to present your research to 80+ attendees from Europe’s large pharma and…
Read More...